Document is current

Any future updates will be listed below

Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

Crossref DOI link: https://doi.org/10.1038/s41375-021-01355-6

Published Online: 2021-11-29

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark